e-learning
resources
European Respiratory Review
2019
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Influence of the lung microbiome on antibiotic susceptibility of cystic fibrosis pathogens
Eva Vandeplassche, Sarah Tavernier, Tom Coenye, Aurélie Crabbé
Source:
Eur Respir Rev, 28 (152) 190041; 10.1183/16000617.0041-2019
Journal Issue:
June
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Eva Vandeplassche, Sarah Tavernier, Tom Coenye, Aurélie Crabbé. Influence of the lung microbiome on antibiotic susceptibility of cystic fibrosis pathogens. Eur Respir Rev, 28 (152) 190041; 10.1183/16000617.0041-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Emerging pathogens in cystic fibrosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=66
Year: 2006
Bacterial infection and lung function in patients with cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 615s
Year: 2005
Chronic but not intermittent infection with
Pseudomonas aeruginosa
is associated with global changes of the lung microbiome in cystic fibrosis
Source: Eur Respir J, 50 (4) 1701086; 10.1183/13993003.01086-2017
Year: 2017
Managing antimicrobial resistance in cystic fibrosis
Source: International Congress 2014 – ERS/Lancet and Lancet Respiratory Medicine joint session: complicating infections in respiratory disease and critical care
Year: 2014
Antibiotic treatment of cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 188-202
Year: 2014
Effect of microbial communities on antimicrobial drug efficacy and host inflammation in Cystic Fibrosis
Source: ERS Lung Science Conference 2019
Year: 2019
Pyrosequencing reveals transient cystic fibrosis lung microbiome changes with intravenous antibiotics
Source: Eur Respir J 2014; 44: 922-930
Year: 2014
Susceptibility of problem respiratory pathogens to levofloxacin in cystic fibrosis (CF)
Source: Eur Respir J 2002; 20: Suppl. 38, 526s
Year: 2002
Longitudinal monitoring of sinonasal and oral bacterial reservoirs to prevent chronic lung infection in people with cystic fibrosis
Source: ERJ Open Res, 6 (3) 00115-2020; 10.1183/23120541.00115-2020
Year: 2020
Ivacaftor/lumacaftor changes the lung microbiome and metabolome in cystic fibrosis patients
Source: Virtual Congress 2020 – Advances in cystic fibrosis: from microbiome to MRI
Year: 2020
Effect of long term treatment with azithromycin on clinical status and lung function parameters in cystic fibrosis patients colonised by pseudomonas aeruginosa
Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research
Year: 2009
Temporal progression of fungal microbiota in patients with cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Year: 2015
Fungal colonization in interstitial lung diseases
Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases
Year: 2011
Management of the CF lung pathogens
Source: ERS course 2015
Year: 2015
The cystic fibrosis lung microenvironment alters antibiotic activity: causes and effects
Source: Eur Respir Rev, 30 (161) 210055; 10.1183/16000617.0055-2021
Year: 2021
Current concepts: host–pathogen interactions in cystic fibrosis airways disease
Source: Eur Respir Rev 2014; 23: 320-332
Year: 2014
Update on management of lung infection in cystic fibrosis
Source: Virtual Congress 2020 – Updates in cystic fibrosis
Year: 2020
What damages the cystic fibrosis lung epithelium: host or microbe?
Source: Virtual Congress 2021 – Innate immunity and lung epithelial repair: what really happens?
Year: 2021
Emerging pathogens in cystic fibrosis
Source: International Congress 2019 – State of the art session: Paediatric respiratory diseases
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept